Nanocarry Therapeutics

Nanoparticle-based Therapeutics for Brain Cancer and CNS Disorders

Active Pre-Seed Startup Ness Ziona Founded 2021-01

Nanocarry is developing therapeutics based on bioengineered nanoparticles with novel capabilities to treat oncology indications and brain diseases. The company’s AxS platform can be easily modified to deliver a wide array of biologics, safely and effectively, to the brain and beyond. Nanocarry’s first products in development are for brain metastases of HER2…

SectorHealth Tech & Life Sciences
StagePre-Seed
Total raised$1.0M
Employees11
Founded2021-01
HQNess Ziona
Confidence88
Sectors
Health Tech & Life SciencesDigital HealthcareDigital TherapeuticsPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals